the GIP question that gets asked weekly, answered properly
Posting this as a discussion rather than a claim: the GIP question that gets asked weekly, answered properly.
Vials and pens carry the same molecule; what differs is fill volume, device tolerance and whether you are doing your own arithmetic. Neither is inherently more accurate.
The four-week interval in the label is a minimum. Nothing about the pharmacology requires you to step on schedule, and the trials stepped on a calendar because trials have to.
SURMOUNT-1 ran 72 weeks with the top arm around 21% mean body weight change. SURPASS is the diabetes programme and reports glycaemic endpoints, so quoting the two interchangeably is a category error.
Corrections welcome, especially the pedantic ones. Pedantry is how this board earns its reputation.
best — the order this archive was captured in
On comparing yourself with the trial number.
SURMOUNT-1 reported roughly 21% mean body weight change at 72 weeks on the highest arm. Three things get dropped every time that figure is quoted here. It is a mean, and the distribution around it is very wide. It is 72 weeks, which is a year and a half. And it is a trial population with trial support, which is not the same as a person with a spreadsheet.
Use it as a rough shape, not a benchmark. A 12% year is inside the ordinary range and people quit over it every week on this board.
Push back: "gentler than sema" is a population statement. Plenty of people on this board have the opposite experience and they are not doing it wrong.
Yes — 10mg being a genuine landing place for a lot of people is underrated. There is no medal for 15.
Not sure that follows. You went up a step and changed your training in the same fortnight.
2.5mg is a four-week starting dose, not a maintenance dose. Worth being precise since people search these threads.
pens and vials are the same molecule, the price is the difference
Agreed, and the trial number is a mean of a very wide distribution — the tails are enormous and nobody posts from the middle.
Disagree with the conversion table. There is no validated equivalence between the two molecules and posting one as though there is does real damage.
Week 7 was the first time the scale moved after a five-week stall. I changed nothing in that window.
the fatigue profile is genuinely gentler than people expect coming from sema
I would separate the two claims. That the GIP arm exists is uncontroversial; that it explains your food noise pattern is a guess.
switching from sema is not a dose conversion, there is no clean equivalence
The 21% figure is a 72-week mean on the highest arm. Quoting it as what someone should expect by week 34 is not a fair reading.
16kg over 42 weeks, never went past 10mg, and fatigue stayed mild the whole way. Posting because the loud threads are all 15mg.
Left up, flair changed to Discussion. It is an opinion post and that is fine as long as it is labelled.
The distribution matters more than the mean. In the trial population the interquartile spread was wide enough that two honest people can have completely different runs on the same arm.
Correction to my own post above — I said 7.5mg and I have been on 15mg since the spring. Same argument, wrong number.
hold the dose that works, the ladder is not a leaderboard
sulphur burps are the signature complaint and they are not dangerous
a lot of people plateau nicely at 10mg and never need 15
Research-use-only material is not approved for human use. Anything in this thread about how a research vial "should" titrate is a discussion about chemistry, not a plan.
It is a dual GIP and GLP-1 receptor agonist, and the GIP arm is the part that has no equivalent in the semaglutide threads. That is why the side-effect profile reads differently rather than just milder.
dual agonist, so the GIP arm is doing something the sema threads will not tell you about
Research-use-only material is not approved for human use.
Agreed, with one qualifier: that is the mean of the top arm and the spread around it was enormous.
- 1Push back: "gentler than sema" is a population statement. Plenty of people…8 comments in this branch · started by u/aksel_kjaer